Invivyd, Inc. Files 8-K on Financials
Ticker: IVVD · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, company-name-change
TL;DR
Invivyd dropped an 8-K detailing financials - check it out.
AI Summary
Invivyd, Inc. filed an 8-K on March 20, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company was formerly known as Adagio Therapeutics, Inc. and changed its name on November 12, 2020.
Why It Matters
This 8-K filing provides an update on Invivyd's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant new risks.
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former company name
- March 20, 2025 (date) — Date of report
- November 12, 2020 (date) — Date of name change
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was Invivyd, Inc. formerly known as Adagio Therapeutics, Inc.?
The company changed its name from Adagio Therapeutics, Inc. on November 12, 2020.
What is the principal executive office address for Invivyd, Inc.?
The principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
What is the SIC code for Invivyd, Inc.?
The Standard Industrial Classification (SIC) code for Invivyd, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What is the filing date of this 8-K report?
The 8-K report was filed on March 20, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Invivyd, Inc. (IVVD).